News GemVax&KAEL Co.,Ltd.

Equities

A082270

KR7082270000

End-of-day quote Korea S.E. Other stock markets 23:00:00 25/06/2024 BST			5-day change	1st Jan Change
10,270 ^KRW	-0.48%		-1.82%	-22.67%

05-02	Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	CI
03-25	GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	05-01	CI
GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	03-24	CI
GemVax&KAEL Co.,Ltd. announced that it expects to receive KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	03-20	CI
Gemvaxlink Co., Ltd. announced that it has received KRW 29.099978456 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd and other investors	03-17	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	31/08/22	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	14/06/22	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	13/06/22	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	13/06/22	CI
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	09/06/22	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	13/04/22	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	12/04/22	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) added to S&P Global BMI Index	20/09/21	CI
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	18/08/21	CI
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	18/08/21	CI
Gemvax & Kael : highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase published in prestigious Alzheimer's Research & Therapy' journal	30/03/21	AQ
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	30/03/21	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) dropped from S&P Global BMI Index	22/03/21	CI
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	06/10/20	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	17/06/20	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	09/06/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GemVax&KAEL Co.,Ltd.

Equities

A082270

KR7082270000

Summary

Filters